Dipartimento Farmaco-Chimico, Università degli Studi di Bari 'Aldo Moro', Via Orabona 4, 70126 Bari, Italy.
Bioorg Med Chem. 2012 Mar 15;20(6):2141-51. doi: 10.1016/j.bmc.2012.01.025. Epub 2012 Jan 28.
PPARs are transcription factors that govern lipid and glucose homeostasis and play a central role in cardiovascular disease, obesity, and diabetes. Thus, there is significant interest in developing new agonists for these receptors. Given that the introduction of fluorine generally has a profound effect on the physical and/or biological properties of the target molecule, we synthesized a series of fluorinated analogs of the previously reported compound 2, some of which turned out to be remarkable PPARα and PPARγ dual agonists. Docking experiments were also carried out to gain insight into the interactions of the most active derivatives with both receptors.
过氧化物酶体增殖物激活受体(PPARs)是调节脂质和葡萄糖稳态的转录因子,在心血管疾病、肥胖症和糖尿病中发挥着核心作用。因此,人们对开发这些受体的新型激动剂有着浓厚的兴趣。鉴于氟原子的引入通常会对靶分子的物理和/或生物学性质产生深远的影响,我们合成了一系列先前报道的化合物 2 的氟化类似物,其中一些化合物被证明是显著的 PPARα 和 PPARγ 双重激动剂。还进行了对接实验,以深入了解最活跃的衍生物与两种受体的相互作用。